Neurotherapeutics
The Journal of the American Society for Experimental NeuroTherapeutics
Editor-in-Chief: Maral Mouradian
ISSN: 1933-7213
(print version)
ISSN: 1878-7479
(electronic version)
Journal no. 13311
- Publishes critical reviews of broad interest on the treatment of neurologic disorders by renowned experts.
- Covers emerging treatments for neurologic disorders.
- Publishes cutting edge original translational research in unmet medical needs for diseases of the nervous system.
- Explores the molecular underpinnings of neurologic diseases as rationale for targeted therapies.
- Provides a platform for publishing points-of-view by key opinion leaders on current hot topics.
Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities.
The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.
Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.
Future Theme Issues:
October 2018- Advances and Challenges in the Diagnosis and Management of Myopathies Guest Editor: Andrew Mammen (NIH), Doris Leung (JHMI), Ricardo Roda (JHMI)
January 2019- Innovation and Evolution in Surgical Neurotherapeutics Guest Editor: Mark Richardson (UPMC), Taylor Abel (UPMC)
April 2019- Nucleic Acid-based Therapeutics in Neurology Guest Editor: Robert Brown (U-MASS), Anastasia Khvorova (U-MASS), Jonathan Watts (U-MASS)
July 2019- Protection of the Aging Brain Guest Editor: Andrew Pieper (U Iowa), Alan Lerner (CWRU)
October 2019- Molecular Pathogenesis and Advances in Therapeutics of Trinucleotide Repeat Expansion Disorders Guest Editor: Lisa Ellerby (Buck Inst)
January 2020- Neurobiological Targets in Translational Addiction Research Guest Editor: Jesse Schank (U-GA), Carolina Haass-Koffler (Brown)
Related subjects » Animal Sciences - Neurology - Neuroscience - Surgery
Impact Factor: 5.719 (2017) *
Journal Citation Reports®
Abstracted/Indexed in
Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, PubMedCentral, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, CNKI, CSA Neurosciences Abstracts, Current Abstracts, Current Contents/ Life Sciences, Current Contents/Clinical Medicine, EBSCO Biomedical Reference Collection, EBSCO CINAHL, EBSCO Discovery Service, EBSCO TOC Premier, Gale, Gale Academic OneFile, Gale InfoTrac, OCLC WorldCat Discovery Service, ProQuest Biological Science Database, ProQuest Central, ProQuest Health & Medical Collection, ProQuest Health Research Premium Collection, ProQuest Medical Database, ProQuest Natural Science Collection, ProQuest Nursing & Allied Health Database, ProQuest Pharma Collection, ProQuest Psychology Database, ProQuest SciTech Premium Collection, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys
Read this Journal on Springerlink
For authors and editors
- 2017 Impact Factor
- 5.719
-
Aims and Scope
Aims and Scope
CloseNeurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities.
The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.
Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.
Future Theme Issues:
October 2018- Advances and Challenges in the Diagnosis and Management of Myopathies Guest Editor: Andrew Mammen (NIH), Doris Leung (JHMI), Ricardo Roda (JHMI)
January 2019- Innovation and Evolution in Surgical Neurotherapeutics Guest Editor: Mark Richardson (UPMC), Taylor Abel (UPMC)
April 2019- Nucleic Acid-based Therapeutics in Neurology Guest Editor: Robert Brown (U-MASS), Anastasia Khvorova (U-MASS), Jonathan Watts (U-MASS)
July 2019- Protection of the Aging Brain Guest Editor: Andrew Pieper (U Iowa), Alan Lerner (CWRU)
October 2019- Molecular Pathogenesis and Advances in Therapeutics of Trinucleotide Repeat Expansion Disorders Guest Editor: Lisa Ellerby (Buck Inst)
January 2020- Neurobiological Targets in Translational Addiction Research Guest Editor: Jesse Schank (U-GA), Carolina Haass-Koffler (Brown)
- Submit Online
- Open Choice - Your Way to Open Access
- Instructions for Authors (pdf, 200 kB)
- Conflict of Interest Form (pdf, 494 kB)
Services for the Journal
- Contacts
- Download Product Flyer
-
Shipping Dates
Shipping Dates
Close- 2019 1/16 01.02.19
Alerts for this journal
Get the table of contents of every new issue published in Neurotherapeutics.
